John Sampson, MD
Affiliations: | 2014- | Neurosurgery | Duke University, Durham, NC |
Google:
"John Sampson"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Brown M, Zhang G, Stevenson K, et al. (2021) BIOM-20. TUMOR-INTRINSIC AND PERIPHERAL FEATURES ASSOCIATE WITH SURVIVAL AFTER POLIO VIROTHERAPY IN RECURRENT GBM Neuro-Oncology. 23: vi14-vi15 |
| Brady M, Raghavan R, Sampson J. (2020) Determinants of Intraparenchymal Infusion Distributions: Modeling and Analyses of Human Glioblastoma Trials. Pharmaceutics. 12 |
| Batich KA, Mitchell DA, Healy P, et al. (2020) Once, Twice, Three Times a Finding: Reproducibility of Dendritic Cell Vaccine Trials Targeting Cytomegalovirus in Glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Evgin L, Huff AL, Wongthida P, et al. (2020) Oncolytic virus-derived type I interferon restricts CAR T cell therapy. Nature Communications. 11: 3187 |
| Reardon DA, Brandes AA, Omuro A, et al. (2020) Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial. Jama Oncology |
| Desjardins A, Randazzo D, Chandramohan V, et al. (2020) CTIM-23. A PHASE 1 TRIAL OF D2C7-IT IN COMBINATION WITH ATEZOLIZUMAB IN RECURRENT WHO GRADE IV MALIGNANT GLIOMA (MG) Neuro-Oncology. 22: ii38-ii38 |
| Sampson J, Achrol A, Aghi M, et al. (2020) CTIM-13. CLINICAL EFFICACY OF MDNA55, AN INTERLEUKIN-4 RECEPTOR TARGETED IMMUNOTHERAPY, IN RECURRENT GBM DELIVERED BY CONVECTION ENHANCED DELIVERY (CED) Neuro-Oncology. 22: ii35-ii35 |
| Desjardins A, Gromeier M, Herndon JE, et al. (2019) Oncolytic polio/rhinovirus recombinant (PVSRIPO) against WHO grade IV malignant glioma (MG): Experience with retreatment of survivors from the phase I trial. Journal of Clinical Oncology. 37: 2060-2060 |
| Evgin L, Huff AL, Wongthida P, et al. (2019) Abstract A029: Unexpected antagonism between oncolytic virus derived type I interferon and EGFRvIII CAR T-cells Cancer Immunology Research. 7 |
| Landi D, Archer G, Driscoll T, et al. (2019) Pdct-10. Feasibility Of Leukapheresis For Harvesting Monocytes And Generating Autologous Dendritic Cell Vaccines In Children With Malignant Brain Tumors Neuro-Oncology. 21 |